Conflict of interest reporting by authors involved in promotion of off-label drug use: An analysis of journal disclosures

Aaron Kesselheim and colleagues investigate conflict of interest disclosures in articles authored by physicians and scientists identified in whistleblower complaints alleging illegal off-label marketing by pharmaceutical companies.

Original Source

Publication Date: 
07/08/2012
Aaron S. Kesselheim, Bo Wang, David M. Studdert & et al
PLoS Medicine
9
8
1-9
Attachment(s): 
Off-Label Drug Use.pdf
Tags:
Drug Industry, Drugs, Scientists, Health Personnel, Science Journalism, United States Of America (US), Information, Research, Multinational Corporations (MNCs)